Viola di Gamba von Joachim Tilke in Hamburg 1697 : Aus dem Bayerischen National Museum

Signatur des Originals: S 36/F11883

Fritz Reuter Villa, Fritz Reuter und Richard Wagner Museum

Signatur des Originals: S 36/F11951

Nicolaus Oesterlein's Richard Wagner-Museum in Wien

Signatur des Originals: S 36/F11957

Plastik aus dem Kensington Museum in London, 1910

Signatur des Originals: S 36/F12109

Sergei Rachmaninoff's Portraits from the collection of the State Central Museum of Musical Culture (Glinka Museum)

Signatur des Originals: S 36/F12277

Sergei Rachmaninoff's Portraits from the collection of the State Central Museum of Musical Culture (Glinka Museum)

Signatur des Originals: S 36/F12278

Sergei Rachmaninoff's Portraits from the collection of the State Central Museum of Musical Culture (Glinka Museum)

Signatur des Originals: S 36/F12279

Sergei Rachmaninoff's Portraits from the collection of the State Central Museum of Musical Culture (Glinka Museum)

Signatur des Originals: S 36/F12280

Sergei Rachmaninoff's Portraits from the collection of the State Central Museum of Musical Culture (Glinka Museum)

Signatur des Originals: S 36/F12281

Sergei Rachmaninoff's Portraits from the collection of the State Central Museum of Musical Culture (Glinka Museum)

Signatur des Originals: S 36/F12282

Sergei Rachmaninoff's Portraits from the collection of the State Central Museum of Musical Culture (Glinka Museum)

Signatur des Originals: S 36/F12283

Sergei Rachmaninoff's Portraits from the collection of the State Central Museum of Musical Culture (Glinka Museum)

Signatur des Originals: S 36/F12284

The Merry Musician. From the painting by Gerrit van Honthorst. In the Museum at Amsterdam

Signatur des Originals: S 36/G04512

Genotypic spectrum and genotype-phenotype correlation of trimethylaminuria

Trimethylaminuria (TMAU) or Fish odor syndrome is an autosomal recessive disease that is characterized by pungent body odor with subsequent psychosocial complications. There are limited studies of the sequence variants causing TMAU in the literature with most studies describing only one or two patients and lacking genotype-phenotype correlations. Also to date, there is no laboratory in the US or Europe that offers TMA genetic testing on a clinical basis. We have recently validated genetic testing in the University of Colorado DNA Diagnostic Laboratory. We have a database of a few dozen patients with a biochemical diagnosis of TMA at the University of Colorado at Denver Health Sciences Center (UCDHSC) which includes a few patients with the classical form of the disease. We have used the newly established clinical test in our institution to attempt to characterize the genotype (sequence variants including mutations and polymorphisms) of classical TMAU patients and to establish a genotype-phenotype (biochemical and clinical) association. The questionnaire results confirmed most of the previously reported epidemiological findings of TMAU and also indicated that TMAU patients use multiple intervention measures in attempt to control their symptoms with dietary control being most effective. Despite the complexity of intervention, most patients did not have any medical follow up and there was underutilization of specialist care. In a set of our patients, two deleterious mutations were identified in 4/12 patients including a novel T237P sequence variant, while the majority of our patients (8/12) did not reveal any mutations. Some of the latter were double heterozygous for the E158K and E308G polymorphisms which could explain a mild phenotype while others had only the E158K variant which raised the question of undetected mutations. These results indicate that further experiments are needed to further delineate the full mutational spectrum of the FMO3 gene. ^

Health care policy analysis of Medicaid's early and periodic screening, diagnosis, and treatment (EPSDT) benefit in Colorado

The purpose of this thesis is to identify "best practice" recommendations for successful implementation of the EPSDT outreach program at Memorial Health System's Hospital for Children in Colorado Springs through a policy analysis of Medicaid EPSDT services in Colorado. A successful program at Memorial will increase education and awareness of EPSDT services, enrollment, and access to and utilization of health care services for eligible children. Methodology utilized in this study included questionnaires designed for the EPSDT contract administrator and outreach coordinators/workers; analysis of current federal and state policies; and studies conducted at the federal and state level, and by various advocacy groups. The need for this analysis of EPSDT came about in part through an awareness of increasingly high numbers of children in poverty and who are uninsured. Though the percentage of children living in poverty in Colorado is slightly below the national average (see Table 2), according to data analyzed by The Annie E. Casey Foundation, the percentage of children (0-18) living in poverty in Colorado increased from 10% in 2000 to 16% in 2006, a dramatic increase of 60% surpassed by only one other state in the nation (The Annie E. Casey Foundation, 2008). By comparison, the U.S. percentage of children in poverty during the same time frame rose from 17% to 18% (The Annie E. Casey Foundation, 2008). What kind of health care services are available to this vulnerable and growing group of Coloradans, and what are the barriers that affect their enrollment in, access to and utilization of these health care services? Barriers identified included difficulty with the application process; system and process issues; a lack of providers; and a lack of awareness and knowledge of EPSDT. Fiscal restraints and legislation at the federal and state level are also barriers to increasing enrollment and access to services. Outreach services are a critical component of providing EPSDT services, and there were several recommendations regarding outreach and case management that will benefit the program in the future. Through this analysis and identification of a broad range of barriers, a clearer picture emerged of current challenges within the EPSDT program as well as a broad range of strategies and recommendations to address these challenges. Through increased education and advocacy for EPSDT and the services it encompasses; stronger collaboration and cooperation between all groups involved, including providing a Medical Home for all eligible children; and new legislation putting more money and focus on comprehensive health care for low-income uninsured children; enrollment, access to and utilization of developmentally appropriate and quality health care services can be achieved. ^